Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus

Brain Res. 2006 May 23;1090(1):182-9. doi: 10.1016/j.brainres.2006.03.060. Epub 2006 May 2.

Abstract

Increased production of reactive oxygen species (ROS) following cerebral ischemia-reperfusion (I/R) is an important underlying cause for neuronal injury leading to delayed neuronal death (DND). In this study, apocynin, a specific inhibitor for NADPH oxidase, was used to test whether suppression of ROS by the NADPH oxidase inhibitor can protect against ischemia-induced ROS generation and decrease DND. Global cerebral ischemia was induced in gerbils by a 5-min occlusion of bilateral common carotid arteries (CCA). Using measurement of 4-hydroxy-2-nonenal (HNE) as a marker for lipid peroxidation, apocynin (5 mg/kg body weight) injected i.p. 30 min prior to ischemia significantly attenuated the early increase in HNE in hippocampus measured at 3 h after I/R. Apocynin also protected against I/R-induced neuronal degeneration and DND, oxidative DNA damage, and glial cell activation. Taken together, the neuroprotective effects of apocynin against ROS production during early phase of I/R and subsequent I/R-induced neuronal damage provide strong evidence that inhibition of NADPH oxidase could be a promising therapeutic mechanism to protect against stroke damage in the brain.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acetophenones / pharmacology*
  • Aldehydes / metabolism
  • Animals
  • Antioxidants / pharmacology
  • Biomarkers / metabolism
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / metabolism
  • Brain Ischemia / physiopathology
  • Cell Death / drug effects
  • Cell Death / physiology
  • Cerebral Infarction / drug therapy*
  • Cerebral Infarction / physiopathology
  • Cerebral Infarction / prevention & control
  • DNA Damage / drug effects
  • DNA Damage / physiology
  • Disease Models, Animal
  • Enzyme Inhibitors / pharmacology
  • Gerbillinae
  • Gliosis / drug therapy
  • Gliosis / etiology
  • Gliosis / prevention & control
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Hippocampus / physiopathology
  • Male
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / metabolism
  • Nerve Degeneration / drug therapy
  • Nerve Degeneration / physiopathology
  • Nerve Degeneration / prevention & control
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology
  • Neuroprotective Agents / pharmacology
  • Oxidative Stress / drug effects*
  • Oxidative Stress / physiology
  • Reactive Oxygen Species / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism
  • Reperfusion Injury / drug therapy*
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / physiopathology
  • Time Factors
  • Treatment Outcome

Substances

  • Acetophenones
  • Aldehydes
  • Antioxidants
  • Biomarkers
  • Enzyme Inhibitors
  • Neuroprotective Agents
  • Reactive Oxygen Species
  • acetovanillone
  • NADPH Oxidases
  • 4-hydroxy-2-nonenal